Design of Enzyme Inhibitors as Drugs, Volume 2 by Merton Sandler

Design of Enzyme Inhibitors as Drugs, Volume 2

EditorMerton Sandler, H. John Smith

Hardcover | April 1, 1995

not yet rated|write a review

Pricing and Purchase Info

$457.50

Earn 2288 plum® points

Ships within 1-3 weeks

Ships free on orders over $25

Not available in stores

about

Outlining the latest developments in the design of enzyme inhibitors as potent drugs in the treatment of disease and infection, Volume 2 extends on the previous volume in providing a comprehensive coverage of more recently recognised target enzymes and their known inhibitors. It demonstrates how the drug designer uses all available information to develop a specific therapeutic agent. The text outlines the steps involved in developing these drugs - from initial inception to satisfactory marketing - a process thwart with potential difficulties and involving the skills ofchemists, biochemists, pharmacologists, and clinicians.A fascinating insight into the world of drug development, this second volume will certainly maintain the position as the text in this field.

About The Author

Merton Sandler, Professor of Chemical Pathology, Royal Postgraduate Medical School, University of London. H. John Smith, Senior Lecturer in Medicinal Chemistry, Welsh School of Pharmacy, University of Wales College of Cardiff.
Nervous Laughter
Nervous Laughter

by Merton Sandler

$53.10

In stock online

Not available in stores

Details & Specs

Title:Design of Enzyme Inhibitors as Drugs, Volume 2Format:HardcoverDimensions:848 pages, 9.21 × 6.14 × 0.01 inPublished:April 1, 1995Publisher:Oxford University Press

The following ISBNs are associated with this title:

ISBN - 10:0192621343

ISBN - 13:9780192621344

Look for similar items by category:

Customer Reviews of Design of Enzyme Inhibitors as Drugs, Volume 2

Reviews

Extra Content

Table of Contents

Preface1. Enzyme inhibitors as drugs: from design to the clinic2. Computer-aided molecular design of enzyme inhibitors3. Protein serine - threonine kinases4. Inhibitors of protein tyrosine kinases5. Inhibitors of non-protein kinases6. Enzyme targets as an approach to therapy for HIV infections7. Inhibitors of viral DNA Polymerase8. Fungal enzyme targets9. Steroidogenesis pathway enzymes10. HMG-Co A reductase inhibitors11. DNA topoisomerases12. Catecholamine - O- methyltrasnferase (COMT) and COMT inhibitors13. Inhibitors of Phospholipase A14. Inhibitors of gastric H+, K+ ATPase15. Inhibitors of mammalian collagenases16. Inhibitors of Aldose Reductase17. Miscellaneous topics